LIF and cancer: It was demonstrated that the leukemia inhibitory factor (LIF) belonging to the IL-6 family of cytokines provided a pro-dormancy signal to tumor cells, with dormant cancer cells being LIF-responsive, compared to colonizing metastatic cells that did not respond to LIF [82–84].